ITGR(Integer Holdings Corporation) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $1.22B | $1.33B | $1.56B | $1.72B | $1.85B |
| 毛利润 | $336.97M | $345.76M | $409.89M | $459.01M | $500.39M |
| 营业利润 | $135.71M | $112.68M | $163.32M | $208.24M | $221.26M |
| 净利润 | $96.81M | $66.38M | $90.65M | $119.90M | $102.81M |
| 经营现金流 | $156.67M | $116.38M | $180.21M | $205.21M | $196.15M |
| 自由现金流 | $103.20M | $41.65M | $60.27M | $99.85M | $105.12M |
| 摊薄每股收益 | $2.91 | $1.99 | $2.69 | $3.36 | $2.89 |